WebDisclosure WebDisclosure
Basculer en Français
11289 Companies
250811 Keywords
179538 Articles
136599 Press releases
Headlines Articles Press releases Aurisco Pharmaceutical Remove
  1. Home
  2. Companies
  3. Aurisco Pharmaceutical
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 08/12/2026 at 21:10, 2 months 23 days ago

    Aurisco Pharmaceutical Passes USFDA Inspection as First Generic Oligonucleotide Manufacturer

    Aurisco Pharmaceutical USFDA Inspection Generic Oligonucleotide TIDES Manufacturing Inclisiran Sodium
  • BRIEF

    published on 08/12/2026 at 21:10, 2 months 23 days ago

    Aurisco Pharmaceutical réussit l'inspection de la FDA américaine en tant que premier fabricant d'oligonucléotides génériques

    Inspection De La FDA Américaine Aurisco Pharmaceutical Inclisiran Sodium Oligonucléotide Générique Fabrication TIDES
  • PRESS RELEASE

    published on 08/12/2026 at 21:05, 2 months 23 days ago

    Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA

    Aurisco Pharmaceutical, a global Oligonucleotide and Peptide manufacturer, becomes the first generic oligonucleotide API manufacturer in the world to pass USFDA inspection. The inspection sets a new standard for safe and affordable oligonucleotides
    Aurisco Pharmaceutical USFDA Inspection Generic Oligonucleotide Manufacturer Inclusiran Sodium Generic TIDES
    Logo of Aurisco Pharmaceutical
Accesswire
  • Published on 11/05/2026 at 15:20, 12 minutes ago

    MicroVision and LAKE FUSION Technologies Sign Multi-Year Strategic Partnership Agreement for IRIS(TM) Lidar Sensors

  • Published on 11/05/2026 at 14:31, 1 hour 1 minute ago

    First Breach Close-Quarters Strike (CQS) Drone Successfully Completes Full Mission Profile

  • Published on 11/05/2026 at 14:25, 1 hour 7 minutes ago

    Polaris Renewable Energy Announces Q3 2026 Results

  • Published on 11/05/2026 at 14:20, 1 hour 12 minutes ago

    Polaris Renewable Energy Declares Quarterly Dividend

  • Published on 11/05/2026 at 14:15, 1 hour 17 minutes ago

    Loar Holdings Inc. Reports Q3 2026 Record Results and Upward Revision to 2026 Outlook and Full Year 2027 Outlook

View all ACCESSWIRE
EQS Group
  • Published on 11/05/2026 at 15:10, 21 minutes ago

    Center for Creative Leadership Names Patrick Mullane President and Chief Executive Officer

  • Published on 11/05/2026 at 14:58, 33 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

  • Published on 11/05/2026 at 14:58, 33 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.

  • Published on 11/05/2026 at 14:57, 34 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: DCC plc

  • Published on 11/05/2026 at 14:57, 34 minutes ago

    Form 8.3 - The Vanguard Group, Inc.: Rotork plc

View all EQS
Les Echos
  • Published on 11/05/2026 at 15:01, 30 minutes ago

    Chiffre d'Affaires du 1er semestre de l'exercice 2026/2027

  • Published on 11/05/2026 at 10:16, 5 hours 15 minutes ago

    Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %

  • Published on 11/05/2026 at 10:16, 5 hours 15 minutes ago

    Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%

  • Published on 11/05/2026 at 07:44, 7 hours 47 minutes ago

    Résultats d’ENGIE 9 mois 2026

  • Published on 11/05/2026 at 07:44, 7 hours 47 minutes ago

    ENGIE 9M 2026 results

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy